Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Access to the study page now displays a 403 Forbidden error instead of the study record content, blocking the trial details. The change replaces the page content with an error screen while keeping the site chrome visible.
    Difference
    18%
    Check dated 2026-09-21T22:30:03.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.5 to v3.6.6, reflecting a minor update to the document's metadata.
    Difference
    0.1%
    Check dated 2026-08-31T17:36:38.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Funding attribution for 2015 (NIH grant/contract) was added to the study record. This addition provides context about the funding source behind the trial.
    Difference
    0.1%
    Check dated 2026-08-24T19:15:52.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a minor administrative update to the page. This change does not modify the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-10T13:47:21.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page's revision is updated from v3.6.3 to v3.6.4. This indicates a new version release for the study record page.
    Difference
    0.1%
    Check dated 2026-07-27T06:20:54.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing Revision: v3.6.2. This reflects an updated revision of the study record.
    Difference
    0.1%
    Check dated 2026-07-05T13:26:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.